Skip to content

Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding

Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01821326
Enrollment
339
Registered
2013-04-01
Start date
2002-06-30
Completion date
Unknown
Last updated
2017-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Bleeding

Keywords

capsule endoscopy, obscure gastrointestinal bleeding, rebleeding, risk factors

Brief summary

The investigators investigated the rebleeding rate the risk factors for rebleeding after long-term follow-up (≥12 months) in patients who underwent capsule endoscopy for obscure gastrointestinal bleeding.

Interventions

None listed

Sponsors

Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Patients who underwent capsule endoscopy in Shanghai Renji Hospital(China) from June 2002 to January 2012 for obscure gastrointestinal bleeding

Exclusion criteria

1. patients who did not undergo a gastroscopy and colonoscopy performed before capsule endoscopy examination; and 2. patients with follow-up examination for other know clinical diseases.

Design outcomes

Primary

MeasureTime frame
Rebleeding Rate10 years

Participant flow

Participants by arm

ArmCount
Patients With Obscure Gastrointestinal Bleeding339
Total339

Baseline characteristics

CharacteristicPatients With Obscure Gastrointestinal Bleeding
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
139 Participants
Age, Categorical
Between 18 and 65 years
200 Participants
Age, Continuous55 years
STANDARD_DEVIATION 18.4
Gender
Female
162 Participants
Gender
Male
177 Participants
Region of Enrollment
China
339 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 339
serious
Total, serious adverse events
0 / 339

Outcome results

Primary

Rebleeding Rate

Time frame: 10 years

ArmMeasureValue (NUMBER)
Patients With Obscure Gastrointestinal BleedingRebleeding Rate97 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026